Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin
- PMID: 3530303
- PMCID: PMC1401112
- DOI: 10.1111/j.1365-2125.1986.tb05243.x
Influence of nisoldipine on haemodynamic effects and plasma levels of digoxin
Abstract
In a placebo controlled double-blind study including 10 patients with heart failure the nisoldipine/digoxin interaction was studied. Nisoldipine was shown to elevate digoxin plasma concentrations significantly by about 15% (trough levels). During chronic combination therapy with nisoldipine trough levels and plasma concentrations 4 h after the morning dose of digoxin were 1.35 +/- 0.14 and 1.92 +/- 0.16 ng ml-1 respectively, whereas they averaged to 1.16 +/- 0.14 and 1.52 +/- 0.16 ng ml-1 with digoxin and placebo (P less than 0.05; mean +/- s.e. mean). Systolic time intervals were significantly altered by nisoldipine co-administration compared with digoxin plus placebo. In certain patients the elevation of digoxin plasma levels due to nisoldipine co-administration could be of clinical relevance.
Similar articles
-
A comparison of the haemodynamic effects of nifedipine, nisoldipine and nitrendipine in man.Eur J Clin Pharmacol. 1986;30(4):393-7. doi: 10.1007/BF00607950. Eur J Clin Pharmacol. 1986. PMID: 2943594 Clinical Trial.
-
Nisoldipine, a new calcium antagonist, elevates plasma levels of digoxin.Arch Toxicol Suppl. 1987;11:310-2. doi: 10.1007/978-3-642-72558-6_59. Arch Toxicol Suppl. 1987. PMID: 3477190 No abstract available.
-
Hemodynamic effects of nisoldipine in chronic congestive heart failure.Arzneimittelforschung. 1983;33(6):877-9. Arzneimittelforschung. 1983. PMID: 6684444
-
[Calcium antagonists in congestive heart failure].G Ital Cardiol. 1988 Nov;18(11):989-96. G Ital Cardiol. 1988. PMID: 3073994 Review. Italian. No abstract available.
-
Actions of nisoldipine in cardiovascular disease.Can J Cardiol. 1989 Jun-Aug;5(5):266-74. Can J Cardiol. 1989. PMID: 2667729 Review.
Cited by
-
Clinical pharmacokinetics of nisoldipine coat-core.Clin Pharmacokinet. 1998 Sep;35(3):191-208. doi: 10.2165/00003088-199835030-00003. Clin Pharmacokinet. 1998. PMID: 9784933 Review.
-
Comparison of information on the pharmacokinetic interactions of Ca antagonists in the package inserts from three countries (Japan, USA and UK).Eur J Clin Pharmacol. 2005 Aug;61(7):531-6. doi: 10.1007/s00228-005-0974-x. Epub 2005 Jul 23. Eur J Clin Pharmacol. 2005. PMID: 16041596
-
The interaction of the calcium antagonist RO 40-5967 with digoxin.Br J Clin Pharmacol. 1995 May;39(5):491-6. doi: 10.1111/j.1365-2125.1995.tb04485.x. Br J Clin Pharmacol. 1995. PMID: 7669484 Free PMC article. Clinical Trial.
-
Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.Clin Pharmacokinet. 1988 Nov;15(5):295-318. doi: 10.2165/00003088-198815050-00003. Clin Pharmacokinet. 1988. PMID: 2849518 Review.
-
Clinical pharmacokinetics of calcium antagonists. An update.Clin Pharmacokinet. 1992 Jun;22(6):416-33. doi: 10.2165/00003088-199222060-00002. Clin Pharmacokinet. 1992. PMID: 1587055 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical